Browse > Article

The Changes of Blood Biochemical Values during Warfarin Therapy in Calves  

임건태 (제주대학교 농과대학 수의학과)
윤영민 (제주대학교 농과대학 수의학과)
이경갑 (제주대학교 농과대학 수의학과)
Publication Information
Journal of Veterinary Clinics / v.20, no.1, 2003 , pp. 74-78 More about this Journal
Abstract
We executed this experiment to observe side effects of warfarin, the anticoagulant that is used for preventing thrombus in cardiovascular surgery for calves. The 6 calves(70-130 kg) were used in this experiment regardless of sexes. We administered warfarin at 0.07 mg/kg daily for 25 days. Blood was collected before warfarin administration, every five days for 30 days. PCV, RBC, WBC, fibrinogen, total protein and platelet as blood test, prothrombin time (PT) as blood coagulation test, and AST, SDH, total bilirubin, BUN and creatinine as serum biochemical tests were measured. As the result of the experiment, PT has been gradually increased after warfarin administration. It has been gradually increased and remains within the therapeutic range from the third day to the 28th day. PCV and RBC were decreased significantly from the value before the administration (p < 0.05). In the serum biochemical test, SDH shows significant increase comparing the value before the administration (p < 0.05). AST and total bilirubin were increased gradually from the value before the administration. Considering the result of the experiment, to give wafarin to prevent thrombus in cardiovascular surgery, we can get anticoagulation effect with minimal administration(0.07 mg/kg, PO) from the third day of the administration. However because of the decreased PCV and RBC, it may cause anemia. It may cause damage to liver based on the result of serum biochemical test.
Keywords
warfarin; PT; blood biochemical values; calf;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Warfarin 과량 사용 후 발생한 Purple Toe 증후군과 동반된 급성 신부전 1예 /
[ 신진호;강경원;김상목;박찬현;강종명;박한철 ] / 대한신장학회지
2 Antithrombotic therapy for venous thromboembolic disease /
[ Hyers TM;Agnelli G;Hull RD;Morris TA;Samama M;Tapson V;Weg JG ] / CHEST   DOI
3 Control of warfarin therapy /
[ Scott DK ] / Post Med J   DOI   ScienceOn
4 /
[ Philip WM;George JB Jr;Joseph PM;Douglas MT ] / Goodman & Gilman's the pharmacological basis of therapeutics(8th ed.)
5 Drugs acting on blood and blood element /
[ Adams HR ] / Veterinary pharmacology and therapeutics(8th ed.)
6 Warfarin: Metabolism and mode of action /
[ Park BK ] / Biochemi Pharmacol
7 /
[ McCurnin DM ] / Clinical textbook for veterinary technicians(4th ed.)
8 /
[ 이귀녕;이종순 ] / 임상병리파일 Ⅱ판
9 Response to warfarin and other oral anticoagulants: effects of disease states /
[ Demirkan K;Stephens MA;Newman KP;Self TH ] / South Med J   DOI
10 Intrahepatic jaundice due to warfarin therapy /
[ Rehnqvist N ] / Acta Med Scand   DOI
11 Gra β1 M. Samples, reagents, assessment of results /
[ Bergmeyer HU;Bergmeyer J ] / Methods of enzymatic analysis
12 Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves /
[ Stein PD;Alpert JS;Bussey HI;Dalen JE;Turpie AGG ] / CHEST   DOI
13 Warfarin sodium(coumadin) anticoagulant therapy for vascular access patency /
[ Kinzner CL ] / ANNA Journal
14 Coumarin-associated hepatitis /
[ Slagboom G;Loeliger EA ] / Arch Intern Med   DOI   ScienceOn
15 Anticoagulation during use of a left ventricular assist device /
[ Takahama T;Kanai F;Onishi K ] / ASAIO J   DOI   ScienceOn
16 /
[ Carter BL;Jones ME;Waickman LA ] / Pathophysiology and treatment of deep-vein thrombosis and pulmonary embolism
17 Therapy of acute thromboembolism with heparin and warfarin /
[ Carter BL ] / Clin Pharm
18 Results of animal experiments using an undulation pump total artificial heart: analysis of 10 day and 19 day survival /
[ Mochizuki S;Abe Y;Chinzei T;Isoyama T;Ono T;Saito I;Guba P;Karita T;Sun YP;Kouno A;Suzuki T;Baba K;Mabuchi K;Imachi K ] / ASAIO J   DOI   ScienceOn
19 항응고제 warfarin 복용환자에서 발생한 위장관 합병증: 공장벽 혈종 및 장중첩증 /
[ 박우찬;김인철 ] / 대한외과학회지
20 /
[ 이창업 ] / 수의 독성학
21 Jarvik 2000 heart potential for bridge to myocyte revovery /
[ Wesaby S;Katsumata T;Houel R;Evans R;Pigoot D;Frazier OH;Jarvik R ] / Circulation
22 Liver damage induced by coumarin anticoagulants /
[ Ehrenforth S;Schenk JF;Scharrer I ] / Semi thrombo hemost   DOI   ScienceOn
23 Frequency of major complications of aspirin, warfarin, and intravenous heparin for secondary stroke prevention /
[ Petty GW;Brown RD Jr;Whisnant JP;Sicks JD;O'Fallon WM;Wiebers DO ] / Ann Intern Med   DOI   ScienceOn
24 Current recommendations for warfarin therapy /
[ Triplett DA ] / Med Clin North Am   DOI   ScienceOn
25 Pharmacology of heparin and warfarin /
[ Wessler S;Gitel SN ] / J Am Coll Cardiol   DOI
26 Combined warfarin and aniplatelet therapy after St. jude medical valve replacement for mitral valve disease /
[ Hayashi J;Nakazawa S;Oguma F;Miyamura H;Eguchi S ] / J Am Coll Cardiol   DOI   ScienceOn